
Peptic Ulcer Drugs Market by Peptic Ulcer Type (Duodenal Ulcer, Gastric Ulcer), Drug Type (Cytoprotective Agents, H2 Blockers, Proton Pump Inhibitors (PPIs)), Distribution Channel - Global Forecast 2024-2030
Description
Peptic Ulcer Drugs Market by Peptic Ulcer Type (Duodenal Ulcer, Gastric Ulcer), Drug Type (Cytoprotective Agents, H2 Blockers, Proton Pump Inhibitors (PPIs)), Distribution Channel - Global Forecast 2024-2030
The Per Diem Nurse Staffing Market size was estimated at USD 9.00 billion in 2023 and expected to reach USD 9.54 billion in 2024, at a CAGR 6.05% to reach USD 13.58 billion by 2030.
Global Per Diem Nurse Staffing Market
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Per Diem Nurse Staffing Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Per Diem Nurse Staffing Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the Per Diem Nurse Staffing Market, highlighting leading vendors and their innovative profiles. These include Accountable Healthcare Staffing, American Medical Staffing, AMN Healthcare, Inc., ATC Healthcare Services, LLC, CareerStaff Unlimited, Cross Country Healthcare, Dedicated Nursing Associates, Inc., Favorite Healthcare Staffing Inc. by Acacium Group, Flexwise Health, Inc., GHR Healthcare, Gifted Healthcare, GrapeTree Medical Staffing, Inc., InGenesis, Inc., Interim HealthCare Inc., and Maxim Healthcare Services, Inc..
Market Segmentation & Coverage
This research report categorizes the Per Diem Nurse Staffing Market to forecast the revenues and analyze trends in each of the following sub-markets:
Service
Emergency Department
Home Care Services
End User
Hospitals
Independent Clinics
Nursing Homes
Region
Americas
Argentina
Brazil
Canada
Mexico
United States
California
Florida
Illinois
New York
Ohio
Pennsylvania
Texas
Asia-Pacific
Australia
China
India
Indonesia
Japan
Malaysia
Philippines
Singapore
South Korea
Taiwan
Thailand
Vietnam
Europe, Middle East & Africa
Denmark
Egypt
Finland
France
Germany
Israel
Italy
Netherlands
Nigeria
Norway
Poland
Qatar
Russia
Saudi Arabia
South Africa
Spain
Sweden
Switzerland
Turkey
United Arab Emirates
United Kingdom
The report offers valuable insights on the following aspects:
1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
The report addresses key questions such as:
1. What is the market size and forecast of the Per Diem Nurse Staffing Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Per Diem Nurse Staffing Market?
3. What are the technology trends and regulatory frameworks in the Per Diem Nurse Staffing Market?
4. What is the market share of the leading vendors in the Per Diem Nurse Staffing Market?
5. Which modes and strategic moves are suitable for entering the Per Diem Nurse Staffing Market?
Note: PDF & Excel + Online Access - 1 Year
Table of Contents
189 Pages
- 1. Preface
- 1.1. Objectives of the Study
- 1.2. Market Segmentation & Coverage
- 1.3. Years Considered for the Study
- 1.4. Currency & Pricing
- 1.5. Language
- 1.6. Limitations
- 1.7. Assumptions
- 1.8. Stakeholders
- 2. Research Methodology
- 2.1. Define: Research Objective
- 2.2. Determine: Research Design
- 2.3. Prepare: Research Instrument
- 2.4. Collect: Data Source
- 2.5. Analyze: Data Interpretation
- 2.6. Formulate: Data Verification
- 2.7. Publish: Research Report
- 2.8. Repeat: Report Update
- 3. Executive Summary
- 4. Market Overview
- 4.1. Introduction
- 4.2. Peptic Ulcer Drugs Market, by Region
- 5. Market Insights
- 5.1. Market Dynamics
- 5.1.1. Drivers
- 5.1.1.1. High prevalence of peptic ulcers with expanding geriatric population
- 5.1.1.2. Growing awareness about peptic ulcers and advancements in diagnostic techniques
- 5.1.1.3. Increasing emphasis on patient-centric care and personalized peptic ulcer treatment
- 5.1.2. Restraints
- 5.1.2.1. High cost of peptic ulcer drugs
- 5.1.3. Opportunities
- 5.1.3.1. Introduction of newer and effective peptic ulcer drugs
- 5.1.3.2. Growing adoption of telemedicine and e-commerce platforms
- 5.1.4. Challenges
- 5.1.4.1. Adverse effects associated with peptic ulcer drugs
- 5.2. Market Segmentation Analysis
- 5.3. Market Trend Analysis
- 5.4. Cumulative Impact of High Inflation
- 5.5. Porter’s Five Forces Analysis
- 5.5.1. Threat of New Entrants
- 5.5.2. Threat of Substitutes
- 5.5.3. Bargaining Power of Customers
- 5.5.4. Bargaining Power of Suppliers
- 5.5.5. Industry Rivalry
- 5.6. Value Chain & Critical Path Analysis
- 5.7. Regulatory Framework
- 6. Peptic Ulcer Drugs Market, by Peptic Ulcer Type
- 6.1. Introduction
- 6.2. Duodenal Ulcer
- 6.3. Gastric Ulcer
- 7. Peptic Ulcer Drugs Market, by Drug Type
- 7.1. Introduction
- 7.2. Cytoprotective Agents
- 7.3. H2 Blockers
- 7.4. Proton Pump Inhibitors (PPIs)
- 8. Peptic Ulcer Drugs Market, by Distribution Channel
- 8.1. Introduction
- 8.2. Offline
- 8.3.1. Hospitals
- 8.3.2. Retail Pharmacies
- 8.3. Online
- 9. Americas Peptic Ulcer Drugs Market
- 9.1. Introduction
- 9.2. Argentina
- 9.3. Brazil
- 9.4. Canada
- 9.5. Mexico
- 9.6. United States
- 10. Asia-Pacific Peptic Ulcer Drugs Market
- 10.1. Introduction
- 10.2. Australia
- 10.3. China
- 10.4. India
- 10.5. Indonesia
- 10.6. Japan
- 10.7. Malaysia
- 10.8. Philippines
- 10.9. Singapore
- 10.10. South Korea
- 10.11. Taiwan
- 10.12. Thailand
- 10.13. Vietnam
- 11. Europe, Middle East & Africa Peptic Ulcer Drugs Market
- 11.1. Introduction
- 11.2. Denmark
- 11.3. Egypt
- 11.4. Finland
- 11.5. France
- 11.6. Germany
- 11.7. Israel
- 11.8. Italy
- 11.9. Netherlands
- 11.10. Nigeria
- 11.11. Norway
- 11.12. Poland
- 11.13. Qatar
- 11.14. Russia
- 11.15. Saudi Arabia
- 11.16. South Africa
- 11.17. Spain
- 11.18. Sweden
- 11.19. Switzerland
- 11.20. Turkey
- 11.21. United Arab Emirates
- 11.22. United Kingdom
- 12. Competitive Landscape
- 12.1. FPNV Positioning Matrix
- 12.2. Market Share Analysis, By Key Player
- 12.3. Competitive Scenario Analysis, By Key Player
- 13. Competitive Portfolio
- 13.1. Key Company Profiles
- 13.1.1. Abbott Laboratories
- 13.1.2. AbbVie Inc.
- 13.1.3. AstraZeneca PLC
- 13.1.4. Boehringer Ingelheim International GmbH
- 13.1.5. Cadila Healthcare Ltd.
- 13.1.6. Century Pharmaceuticals Ltd.
- 13.1.7. Daewoong Pharmaceutical Co. LTD.
- 13.1.8. Dr. Reddy’s Laboratories Ltd
- 13.1.9. Eisai Co. Ltd.
- 13.1.10. F. Hoffmann-La Roche Ltd.
- 13.1.11. GlaxoSmithKline PLC
- 13.1.12. Hikma Pharmaceuticals PLC
- 13.1.13. Medopharm Pvt Ltd
- 13.1.14. Merck KGaA
- 13.1.15. Mylan N.V.
- 13.1.16. Novartis AG
- 13.1.17. Pfizer Inc.
- 13.1.18. Pharmanova India Drugs Pvt. Ltd.
- 13.1.19. Redhill Biopharma Ltd
- 13.1.20. Rosemont Pharmaceuticals Limited
- 13.1.21. Takeda Pharmaceutical Company Limited
- 13.1.22. Teva Pharmaceutical Industries Ltd.
- 13.1.23. Ulcerex Pharma
- 13.1.24. USAntibiotics
- 13.1.25. Yuhan Corporation
- 13.2. Key Product Portfolio
- 14. Appendix
- 14.1. Discussion Guide
- 14.2. License & Pricing
- FIGURE 1. PEPTIC ULCER DRUGS MARKET RESEARCH PROCESS
- FIGURE 2. PEPTIC ULCER DRUGS MARKET SIZE, 2023 VS 2030
- FIGURE 3. PEPTIC ULCER DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
- FIGURE 4. PEPTIC ULCER DRUGS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
- FIGURE 5. PEPTIC ULCER DRUGS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 6. PEPTIC ULCER DRUGS MARKET DYNAMICS
- FIGURE 7. PEPTIC ULCER DRUGS MARKET SIZE, BY PEPTIC ULCER TYPE, 2023 VS 2030 (%)
- FIGURE 8. PEPTIC ULCER DRUGS MARKET SIZE, BY PEPTIC ULCER TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 9. PEPTIC ULCER DRUGS MARKET SIZE, BY DRUG TYPE, 2023 VS 2030 (%)
- FIGURE 10. PEPTIC ULCER DRUGS MARKET SIZE, BY DRUG TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 11. PEPTIC ULCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
- FIGURE 12. PEPTIC ULCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 13. AMERICAS PEPTIC ULCER DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 14. AMERICAS PEPTIC ULCER DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 15. UNITED STATES PEPTIC ULCER DRUGS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
- FIGURE 16. UNITED STATES PEPTIC ULCER DRUGS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 17. ASIA-PACIFIC PEPTIC ULCER DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 18. ASIA-PACIFIC PEPTIC ULCER DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 19. EUROPE, MIDDLE EAST & AFRICA PEPTIC ULCER DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 20. EUROPE, MIDDLE EAST & AFRICA PEPTIC ULCER DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 21. PEPTIC ULCER DRUGS MARKET, FPNV POSITIONING MATRIX, 2023
- FIGURE 22. PEPTIC ULCER DRUGS MARKET SHARE, BY KEY PLAYER, 2023
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.